Synthesis and evaluation of frentizole-based indolyl thiourea analogues as MAO/ABAD inhibitors for Alzheimer's disease treatment
Jazyk angličtina Země Anglie, Velká Británie Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
BB/J01446X/1
Biotechnology and Biological Sciences Research Council - United Kingdom
PubMed
28082069
DOI
10.1016/j.bmc.2016.12.029
PII: S0968-0896(16)31452-3
Knihovny.cz E-zdroje
- Klíčová slova
- 17β-Hydroxysteroid dehydrogenase type 10 (17β-HSD10), Alzheimer's disease (AD), Amyloid-beta peptide (Aβ), Horseradish peroxidase (HRP), Mitochondrial amyloid-binding alcohol dehydrogenase (ABAD), Monoamine oxidase (MAO),
- MeSH
- 3-hydroxyacyl-CoA-dehydrogenasy antagonisté a inhibitory metabolismus MeSH
- Alzheimerova nemoc farmakoterapie metabolismus MeSH
- benzothiazoly chemie farmakologie MeSH
- fenylmočovinové sloučeniny chemie farmakologie MeSH
- inhibitory enzymů chemická syntéza chemie farmakologie MeSH
- lidé MeSH
- molekulární struktura MeSH
- monoaminoxidasa metabolismus MeSH
- thiomočovina chemická syntéza chemie farmakologie MeSH
- vztah mezi dávkou a účinkem léčiva MeSH
- vztahy mezi strukturou a aktivitou MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- 3-hydroxyacyl-CoA-dehydrogenasy MeSH
- benzothiazoly MeSH
- fenylmočovinové sloučeniny MeSH
- frentizole MeSH Prohlížeč
- HSD17B10 protein, human MeSH Prohlížeč
- inhibitory enzymů MeSH
- monoaminoxidasa MeSH
- thiomočovina MeSH
Alzheimer's disease (AD) is a neurodegenerative disorder associated with an excessive accumulation of amyloid-beta peptide (Aβ). Based on the multifactorial nature of AD, preparation of multi-target-directed ligands presents a viable option to address more pathological events at one time. A novel class of asymmetrical disubstituted indolyl thioureas have been designed and synthesized to interact with monoamine oxidase (MAO) and/or amyloid-binding alcohol dehydrogenase (ABAD). The design combines the features of known MAO inhibitors scaffolds (e.g. rasagiline or ladostigil) and a frentizole moiety with potential to interact with ABAD. Evaluation against MAO identified several compounds that inhibited in the low to moderate micromolar range. The most promising compound (19) inhibited human MAO-A and MAO-B with IC50 values of 6.34μM and 0.30μM, respectively. ABAD activity evaluation did not show any highly potent compound, but the compound series allowed identification of structural features to assist the future development of ABAD inhibitors. Finally, several of the compounds were found to be potent inhibitors of horseradish peroxidase (HRP), preventing the use of the Amplex™ Red assay to detect hydrogen peroxide produced by MAO, highlighting the need for serious precautions when using an enzyme-coupled assay.
Citace poskytuje Crossref.org
Nanomolar Benzothiazole-Based Inhibitors of 17β-HSD10 with Cellular Bioactivity
Novel Benzothiazole-based Ureas as 17β-HSD10 Inhibitors, A Potential Alzheimer's Disease Treatment